Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
Recruiting · NCT05938465 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) | Crohn ileitis, Digestive System Diseases, Ileal Diseases, digestive system disorder, enteritis, gastroenteritis, intestinal disorder, pouchitis | Recruiting | Phase 1 / Phase 2 | 2026-05-28 | NCT05938465 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exegi Pharma, LLC | 3 |
| The Emmes Company, LLC | 17 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Corewell Health | Grand Rapids | United States | 45 |
| Mayo Clinic - Florida (Inflammatory Bowel Disease Center) | Jacksonville | United States | 1 |
| Mayo Clinic Department of Gastroenterology | Rochester | United States | 1 |
| NYU Langone Health | New York | United States | 403 |
| Penn State Health (Milton S. Hershey Medical Center) | Hershey | United States | 1 |
| University of North Carolina at Chapel Hill | Chapel Hill | United States | 129 |
| Washington University School of Medicine | St Louis | United States | 895 |